Stereotactic Radiosurgery and Stereotactic Radiotherapy for Malignant Skull Base Tumors.

Area of Science:

• Neurosurgery
• Radiation Oncology
• Head and Neck Surgery

Background:

• Malignant skull base tumors present significant treatment challenges due to difficulties in complete surgical resection.
• Stereotactic radiosurgery/radiotherapy (SRS/SRT) is explored as a therapeutic option for these complex cases.
• The management of skull base tumors requires multidisciplinary approaches, integrating surgery and radiation techniques.

Purpose of the Study:

• To summarize and discuss the role of SRS/SRT in treating malignant skull base tumors.
• To evaluate the efficacy of SRS/SRT for residual, recurrent, and metastatic skull base lesions.
• To review the application of SRS/SRT in early-stage head and neck carcinomas, including nasal, paranasal, and external auditory canal cancers.

Main Methods:

• Review of previously published SRS/SRT results for malignant extra-axial skull base tumors.
• Analysis of treatment outcomes for early-stage head and neck carcinomas from the authors' data and other reported series.
• Literature review to assess the utility of SRS/SRT in specific malignant skull base tumor contexts.

Main Results:

• SRS/SRT is a useful treatment for residual or recurrent primary skull base tumors post-surgery.
• Localized skull base metastases and invasive tumors are potential candidates for SRS/SRT.
• Early-stage nasal/paranasal carcinomas and external auditory canal carcinomas with no lymph node or distant metastasis may be suitable for SRS/SRT as initial therapy.

Conclusions:

• SRS/SRT demonstrates significant utility in managing various malignant skull base tumors.
• The findings support SRS/SRT as a viable treatment modality for specific indications in skull base oncology.
• Further investigation into SRS/SRT for early-stage head and neck malignancies is warranted to clarify its role in initial treatment paradigms.